Omega Therapeutics

Curated by Signal

Provider of platform for human genome study for precision medicine

Life Sciences Technologyomegatherapeutics.com

Overview

Omega Therapeutics provides a platform for human genome study for precision medicine. The company offers its proprietary platform GenomStats for controlling genomic expression without changing nucleic acid sequences and offers precision medicine for diseases like rare genetic diseases, immunology, inflammation, metabolic diseases, and oncology.

Key facts

Founded: 2017
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Atantares
Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies
Life Sciences TechnologyCambridge, United States
Active Motif
Provider of research kits, assays and biocomputing systems
Life Sciences TechnologyCarlsbad, United States
Personalis
Provider of genomic sequencing and diagnosis software for the healthcare industry
Life Sciences TechnologyMenlo Park, United States

About Omega Therapeutics

What does Omega Therapeutics do?

Omega Therapeutics provides a platform for human genome study for precision medicine.

Where is Omega Therapeutics headquartered?

Omega Therapeutics is headquartered in Cambridge, United States.

When was Omega Therapeutics founded?

Omega Therapeutics was founded in 2017.

Which sector is Omega Therapeutics in?

Omega Therapeutics operates in Life Sciences Technology.

Who are Omega Therapeutics's competitors?

Companies similar to Omega Therapeutics include Atantares, Active Motif, and Personalis.